AstraZeneca Says Drug Cocktail Effective Against COVID-19 in Late-Stage Study
The phase 3 trial preliminary results showed the drug cut the risk of developing severe COVID-19 or dying by 50 percent compared to a placebo in people who did not require hospitalization and had been showing symptoms for a week or less.
Vaccine-Maker BioNTech Sees 2nd-Quarter Profits Soar
In an earnings report released on Monday, the Mainz-based company said that it made a net profit of nearly $3.3 billion between April and June.
AstraZeneca Lost Money on COVID-19 Vaccine in First Half of 2021
AstraZeneca said losses on Vaxzevria were the main factor that shaved seven percentage points off its Reported Gross Profit Margin, which fell to 73.5 percent in the first half of the year.
AstraZeneca Made $275 Million Off Its Covid Vaccine
AstraZeneca made most of its sales in Europe during the first quarter.
AstraZeneca ganó $ 275 millones con su vacuna Covid
AstraZeneca realizó la mayor parte de sus ventas en Europa durante el primer trimestre.
One Dose of Pfizer or AstraZeneca Vaccine Can Slow Covid-19 Spread in a Household by About 50%, Study Reveals
Public Health England expects a similar result in places with high transmission risks, such as prisons.
AstraZeneca May Have Used Outdated Data in Vaccine Trial (Updated)
The British-Swedish pharmaceutical will now work with health officials in the U.S. to provide updated efficacy data.
AstraZeneca puede haber usado datos desactualizados en un ensayo de vacunas (actualizado)
La farmacéutica británico-sueca trabajará ahora con funcionarios de salud en los EE. UU. Para proporcionar datos de eficacia actualizados.
AstraZeneca Covid Vaccine 100% Effective Against Hospitalizations and Deaths, Per Final-Stage U.S. Testing
The UK-based pharmaceutical maker's two-shot solution appears to be even more efficacious against symptomatic infection than Johnson & Johnson's one-dose injection.